Imed Infinity Medical-Limited Partnership (TLV:IMED)
Israel · Delayed Price · Currency is ILS · Price in ILA 114.00
0.00 (0.00%)
Apr 20, 2026, 10:56 AM IDT
TLV:IMED Revenue
In the year 2025, Imed Infinity Medical-Limited Partnership had annual revenue of $226.00K USD with 451.22% growth. Imed Infinity Medical-Limited Partnership had revenue of $-431.00K in the half year ending December 31, 2025.
Revenue
$226.00K
Revenue Growth
+451.22%
P/S Ratio
6.38
Revenue / Employee
$2.83K
Employees
80
Market Cap
4.60M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 226.00K | 185.00K | 451.22% |
| Dec 31, 2024 | 41.00K | 983.00K | - |
| Dec 31, 2023 | -942.00K | -1.14M | - |
| Dec 31, 2022 | 200.00K | 125.00K | 166.67% |
| Dec 31, 2021 | 75.00K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.02B |
| Danel (Adir Yeoshua) | 2.90B |
| Amal Holdings A.D. | 2.18B |
| BrainsWay | 166.49M |
| Bio-View | 19.93M |
| Tikun Olam-Cannbit Pharmaceuticals | 9.10M |
| XTL Biopharmaceuticals | 3.26M |
| Can-Fite BioPharma | 1.29M |